These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31511228)
1. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients. Naik S; Martinez CA; Omer B; Sasa G; Yassine K; Allen CE; Kamdar K; Orth R; Wu M; Leung K; Gottschalk S; Brenner MK; Heslop HE; Krance RA Blood Adv; 2019 Sep; 3(18):2689-2695. PubMed ID: 31511228 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas. Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369 [TBL] [Abstract][Full Text] [Related]
3. Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors. Gupta A; Gokarn A; Rajamanickam D; Punatar S; Thippeswamy R; Mathew L; Bagal B; Kannan S; Khattry N J Cancer Res Ther; 2018; 14(5):926-933. PubMed ID: 30197327 [TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation. Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967 [TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757 [TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. Sandlund JT; Bowman L; Heslop HE; Krance R; Mahmoud H; Pui C-; Hale G; Benaim E Cytotherapy; 2002; 4(3):253-8. PubMed ID: 12194721 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning. Rezvani AR; Kanate AS; Efron B; Chhabra S; Kohrt HE; Shizuru JA; Laport GG; Miklos DB; Benjamin JE; Johnston LJ; Arai S; Weng WK; Negrin RS; Strober S; Lowsky R Bone Marrow Transplant; 2015 Oct; 50(10):1286-92. PubMed ID: 26146806 [TBL] [Abstract][Full Text] [Related]
8. [Outcome of haploidentical hematopoietic stem cell transplantation for non-Hodgkin lymphoma]. Xu T; Chen J; Jin ZM; Miao M; Fu CC; Qiu HY; Tang XW; Han Y; Sun AN; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):656-60. PubMed ID: 27587245 [TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Gross TG; Hale GA; He W; Camitta BM; Sanders JE; Cairo MS; Hayashi RJ; Termuhlen AM; Zhang MJ; Davies SM; Eapen M Biol Blood Marrow Transplant; 2010 Feb; 16(2):223-30. PubMed ID: 19800015 [TBL] [Abstract][Full Text] [Related]
10. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma. Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG Ann Hematol; 2019 Jul; 98(7):1743-1753. PubMed ID: 31089793 [TBL] [Abstract][Full Text] [Related]
11. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Freytes CO; Loberiza FR; Rizzo JD; Bashey A; Bredeson CN; Cairo MS; Gale RP; Horowitz MM; Klumpp TR; Martino R; McCarthy PL; Molina A; Pavlovsky S; Pecora AL; Serna DS; Tsai T; Zhang MJ; Vose JM; Lazarus HM; van Besien K; Blood; 2004 Dec; 104(12):3797-803. PubMed ID: 15280203 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant. Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas. Hamadani M; Benson DM; Hofmeister CC; Elder P; Blum W; Porcu P; Garzon R; Blum KA; Lin TS; Marcucci G; Devine SM Biol Blood Marrow Transplant; 2009 May; 15(5):547-53. PubMed ID: 19361746 [TBL] [Abstract][Full Text] [Related]
14. Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. McClune BL; Ahn KW; Wang HL; Antin JH; Artz AS; Cahn JY; Deol A; Freytes CO; Hamadani M; Holmberg LA; Jagasia MH; Jakubowski AA; Kharfan-Dabaja MA; Lazarus HM; Miller AM; Olsson R; Pedersen TL; Pidala J; Pulsipher MA; Rowe JM; Saber W; van Besien KW; Waller EK; Aljurf MD; Akpek G; Bacher U; Chao NJ; Chen YB; Cooper BW; Dehn J; de Lima MJ; Hsu JW; Lewis ID; Marks DI; McGuirk J; Cairo MS; Schouten HC; Szer J; Ramanathan M; Savani BN; Seftel M; Socie G; Vij R; Warlick ED; Weisdorf DJ Biol Blood Marrow Transplant; 2014 Jul; 20(7):960-8. PubMed ID: 24641829 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis. Wang J; Duan X; Yang L; Liu X; Hao C; Dong H; Gu H; Tang H; Dong B; Zhang T; Gao G; Liang R Cell Transplant; 2020; 29():963689720975397. PubMed ID: 33238731 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Bertz H; Illerhaus G; Veelken H; Finke J Ann Oncol; 2002 Jan; 13(1):135-9. PubMed ID: 11863095 [TBL] [Abstract][Full Text] [Related]
17. Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience. Ciochetto C; Botto B; Passera R; Bellò M; Benevolo G; Boccomini C; Castellino A; Chiappella A; Freilone R; Nicolosi M; Orsucci L; Pecoraro C; Pregno P; Bisi G; Vitolo U Ann Hematol; 2018 Sep; 97(9):1619-1626. PubMed ID: 29663029 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma. Bhatt VR; Vose JM Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180 [TBL] [Abstract][Full Text] [Related]
19. Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962. Harris RE; Termuhlen AM; Smith LM; Lynch J; Henry MM; Perkins SL; Gross TG; Warkentin P; Vlachos A; Harrison L; Cairo MS Biol Blood Marrow Transplant; 2011 Feb; 17(2):249-58. PubMed ID: 20637881 [TBL] [Abstract][Full Text] [Related]
20. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status. Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]